Factors
Stocks
Valuation
Portfolio
Visualizations
More
Research date: June 20, 2026
Closing price before research date: $170.85
Current price: $204.63

Cintas Corporation (NASDAQ: CTAS) — A Wide-Moat Compounder That Finally Coughed Up Its Premium

Independent equity research — general information, not investment advice. Report date: 2026-06-20. Cintas fiscal year ends May 31.


⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice and not a recommendation to buy or sell any security. The analysis in the sections below is written to be position-free and carries no price target; the single directional view is fenced inside this block.

Verdict: HOLD / accumulate-on-weakness. A genuine wide-moat compounder, finally off its nosebleed multiple but still not at a value price. Quality you pay up for — just pay up a little less than the crowd did in 2024. Directional zone: I’d treat ~$140–155 (≈19–21x EV/EBITDA, ≈30x forward EPS, low-to-mid own-history percentile) as the comfortable accumulation band for a multi-year holder, and regard today’s ~$171 (~23.6x EV/EBITDA, ~35x forward EPS) as fair-to-slightly-rich — a hold, not a fresh buy.

Cintas is one of the rarest setups in this sector: a business whose ~26% ROIC, 15 consecutive years of operating-margin expansion, ~95% customer retention, and oligopoly route-density moat are real and durable, not a cyclical mirage — and yet the stock has fallen ~24% from its June-2025 peak and shed its momentum bid entirely. That is the opposite of the “great business at its richest-ever multiple” trap. Here the AZI own-history composite sits at the 69th percentile, not the 95th+; the P/E percentile is only the 56th. The market de-rated a 50x P/E to 35x while EPS kept compounding low-double-digits. That is healthy. The catch: 35x forward earnings and a ~2.7% FCF yield still embed years of flawless execution, and the pending $5.3B UniFirst acquisition layers on integration, dilution (~14M new shares), leverage (to ~1.5x) and — per the $350M reverse termination fee and the FTC second request — non-trivial antitrust risk. The framing is quality-compounder-at-a-fairer-but-not-cheap-price, with a deal-overhang kicker; the factor tape confirms it (LowVol/Quality/Dividend loadings, momentum zeroed — an abandoned quality name, not a falling knife and not yet a value name).

Conviction: medium. Flip bullish: organic growth re-accelerates back toward double digits and/or the UniFirst deal clears the FTC and closes accretively — at which point density economics compound on a larger base. Flip bearish: the FTC blocks/extracts heavy divestitures and organic growth decelerates below mid-single-digits as the labor market softens (wearer levels are the company’s single biggest exogenous lever). Tag: “You finally got a sale on the best house on the block — but it’s still not on the clearance rack.”


📈 Stock Price Action — Five-Year Event Map

Over five years CTAS roughly doubled and then gave a quarter of it back: from a ~$83 split-adjusted low (June 2021) to a ~$225 peak (June 2025), now ~$171 (2026-06-18) — down ~24% from the high, inside a 52-week range of $163–$224. The defining feature is not the climb but the 18-month stall-and-slide since mid-2025: a textbook premium-multiple de-rating, accelerated by the UniFirst deal overhang. (Prices split-adjusted for the 4-for-1 split effective September 2024. Price moves are FACT; attributed drivers are INTERPRETATION.)

# Period Approx. move Price (~from → to) Primary driver(s) Fact / Interp
1 FY21 (CY2021) +28% ~$83 → ~$106 Post-COVID employment recovery; uniform wearer levels rebound; margin inflection begins Fact / Interp
2 CY2022 range-bound, ~flat ~$100–110 2022 bear market; CTAS’s low-beta defensiveness drives large relative outperformance Fact / Interp
3 CY2023–Nov 2024 +110% ~$108 → ~$223 Sustained margin expansion + low-double-digit EPS growth + a quality/low-vol re-rating to ~33x EV/EBITDA Fact / Interp
4 Dec 2024 −19% (month) ~$223 → ~$180 Hawkish Fed repricing of long-duration quality + a rich starting multiple; H1 FY25 print Fact / Interp
5 Jan–Jun 2025 recovery to peak ~$180 → ~$225 First public $275 all-cash UniFirst bid (rejected); continued beats Fact / Interp
6 H2 2025 grind lower (−10%+) ~$225 → ~$185 Organic growth decelerating to ~8% as employment cools; multiple compression continues Fact / Interp
7 Mar 2026 −16% (month) ~$185 → ~$169 Definitive UniFirst merger announced (Mar 10) — integration/leverage/dilution + regulatory overhang Fact / Interp
8 Apr–Jun 2026 drift to ~$163–171 ~$169 → ~$171 Deal in regulatory limbo; FTC second request (Jun 11) extends timeline; sell-side PTs trimmed (~$225) Fact / Interp

The arc that matters for valuation: events #3–#4 lifted CTAS to a ~50x P/E / ~33x EV/EBITDA extreme; events #6–#8 worked it back to ~35x / ~23.6x while earnings rose ~25% — i.e., the de-rating did the damage, not a business stumble.


1. Executive Summary

Cintas is the dominant North American provider of route-based uniform rental and facility services — managed workwear programs, floor mats, mops, restroom supplies, first-aid and safety services, and fire protection — serving over one million businesses (average spend ~$10,000/year) through a network of 400+ facilities and thousands of local delivery routes. It is the clear #1 in a consolidating oligopoly, ahead of Aramark/Vestis and (pending acquisition) UniFirst.

The business is genuinely excellent. Revenue grew from $6.9B (FY19) to $10.34B (FY25), a ~7% CAGR that has accelerated to ~8–9% organically. Operating margin expanded from 16.4% to 22.8% — fifteen-plus consecutive years of expansion — and gross margin crossed 50%. Diluted EPS more than doubled, from $2.02 to $4.42, compounding ~14%. Return on invested capital rose from ~16% to ~26%, comfortably above any reasonable cost of capital. The company self-funds: ~$1.8B annual free cash flow, a conservative balance sheet (~0.76x net-debt/EBITDA), steadily rising dividends (a Dividend Aristocrat-class record) and consistent buybacks that have shrunk the diluted share count ~6% over six years.

The moat is real and nameable: a Greenwald economies-of-scale advantage fused with customer captivity. Uniform rental is a local-density game — the operator with the most stops per route in a given metro has a structural cost advantage competitors cannot replicate without the same density. Layer on ~95% annual retention (managed-program switching costs, embedded logistics, contractual terms) and a customer base so fragmented (1M+ accounts, no concentration) that no buyer has leverage, and you have durable pricing power (2–3%/year, every year) and incremental margins of ~28–39%. Industry consolidation — G&K Services ($2.2B, 2017) and now UniFirst ($5.3B, agreed March 2026) — increases density and rationalizes a structurally attractive industry further in Cintas’s favor.

The tension is entirely price and deal risk, not quality. At ~$171 the stock trades at ~35x forward EPS, ~23.6x EV/EBITDA and a ~2.7% FCF yield. That is down meaningfully from the 2024–25 peak (~50x P/E, ~33x EV/EBITDA) — the AZI own-history composite is the 69th percentile, not the 95th — but it is still a premium that embeds years of double-digit compounding. The pending UniFirst deal ($155 cash + 0.772 CTAS shares/UNF share) adds modest accretion and route density but also ~14M shares of dilution, leverage to ~1.5x, integration execution risk, and live antitrust risk now in an FTC second request (underscored by a $350M reverse break fee). This memo takes no position and sets no price target; it argues that Cintas is one of the highest-quality businesses in the industrial-services universe, that the market is correctly pricing that quality at a premium, and that the open questions are whether organic growth holds in a softening labor market and whether the UniFirst deal closes on terms that create rather than consume per-share value.


2. Business Overview

Cintas sells recurring, route-based business services — not products in the one-time sense. Its economic engine is the weekly (or scheduled) physical visit by a Cintas service representative (“SSR”) to a customer location to swap soiled uniforms and mats for clean ones, restock restroom and first-aid supplies, and inspect fire equipment. Revenue is overwhelmingly recurring and contractual, billed on multi-year service agreements with automatic renewal and price-escalation provisions. This is the single most important fact about the business: it is an annuity stream attached to the operating headcount and facility footprint of a million businesses, not a transactional sale.

Reporting segments (FY25, ~$10.34B revenue):

Segment ~% of revenue What it is Gross margin (Q3 FY26)
Uniform Rental & Facility Services ~78% Rented/maintained workwear (incl. flame-resistant), floor mats, mops, shop towels, restroom cleaning/supply 50.3% (record)
First Aid & Safety Services ~12% First-aid cabinets/restocking, AEDs, safety/PPE products, compliance training 58.1% (record)
All Other (Fire Protection + Uniform Direct Sale) ~10% Fire extinguisher/alarm/sprinkler inspection & service; direct (non-rental) uniform sales to large accounts Fire 50.5%; Direct 41.4%

The Uniform Rental & Facility Services segment is the core franchise and the densest moat. First Aid & Safety is the fastest grower (organic +14.6% in Q3 FY26) and the highest-margin segment (~58%), riding the same route infrastructure — a textbook cross-sell adjacency. Fire Protection (inside “All Other”) is a consolidation play (organic +10%), where Cintas prefers recurring service/inspection revenue over lumpy installation. Uniform Direct Sale is the lowest-quality, lumpiest line (organic +3.1%, 41% GM) — large national-account direct purchases rather than rental.

How it makes money: customers pay a weekly/periodic service fee. Cintas owns the garments and mats (capitalized as in-service inventory, a defining balance-sheet feature), launders and repairs them across 400+ plants, and amortizes them over their useful life. The model converts a customer’s messy, labor-intensive in-house chore (buying, laundering, tracking, replacing uniforms) into a single predictable line item — management’s repeated framing is “we let businesses focus on running their business.” Roughly two-thirds of new customers come from the “no-programmer” / do-it-yourself market — businesses currently handling uniforms themselves — not from competitors. That is the key growth insight: Cintas’s primary competitor is in-house DIY and e-commerce/retail, not just UniFirst or Vestis, which is why the addressable market (16–20M businesses, ~180M workers in the U.S./Canada vs. ~1M current Cintas customers) is genuinely large and underpenetrated.

Customers and end markets: highly diversified across manufacturing, healthcare, hospitality, retail, automotive, construction, education, and state/local government. Management explicitly targets four resilient verticals — healthcare, hospitality, education, and state & local government — to dampen cyclicality. Average customer spends ~$10,000/year; national accounts are mostly “hunting licenses” (centralized terms, local purchasing decisions), so even large customers behave like a portfolio of small, low-concentration accounts.

Verdict: A high-quality, recurring, route-based services business with diversified, fragmented demand and a large underpenetrated TAM. The revenue is among the most predictable in the industrials sector. This is a structurally attractive business model before we even reach the moat.


3. Industry Dynamics

The North American uniform rental & facility services industry is a mature, rational oligopoly — the most attractive market structure a capital-cycle analyst can find. After two decades of consolidation, the field is led by Cintas (#1, ~$10B+ revenue), Aramark’s former uniform arm Vestis (spun off 2023) and Aramark Uniform Services, and UniFirst (#3, ~$2.4B) — with a long tail of regional and local operators that Cintas systematically acquires. Post-UniFirst, Cintas’s share of the organized rental market would be larger still.

Market size and growth. The organized uniform/facility-services rental market is mid-single-digit-growth in aggregate, but the penetration story is the real driver: with only ~1M of 16–20M businesses using a managed program, the structural tailwind is conversion of DIY/no-programmer accounts, which lets the leaders grow “multiples of job creation and GDP,” in management’s phrase. Cintas has compounded revenue ~8–9% organically against a low-single-digit end-market — i.e., it is taking share from the unserved market, not just from rivals.

Profit pools and competitive intensity. This is where the industry’s quality shows. Pricing across the industry runs a disciplined 2–3% per year — neither predatory nor extractive — and retention sits in the mid-90s%. There is no destructive price war because the economics are local-density-driven: a route’s profitability depends on stops-per-mile, so the incumbent with density in a metro earns more on the same revenue than a sub-scale entrant could, making share-grabs via price irrational for everyone. New entrants face the chicken-and-egg problem of needing density to be cost-competitive but needing low prices to win density — a genuine barrier to entry. The result: stable share, rational pricing, expanding margins industry-wide.

Regulation and structural factors. Light regulatory burden (the business itself isn’t rate- or reimbursement-regulated), though the segments touch OSHA/safety compliance, FDA-adjacent first-aid standards, and fire codes — all of which create demand (compliance is a selling point) rather than constrain it. The most relevant regulatory exposure is antitrust on consolidation — directly live now via the FTC’s review of the UniFirst deal. Input exposures: cotton/polyester (garments), energy (laundry + fleet fuel, ~1.7% of revenue, only ~60% of which is vehicle fuel), and labor. Tariffs are a watch item but management states impacts are immaterial and slow-moving through the supply chain.

Capital cycle read (Marathon lens). Uniform rental is a consolidating industry where the leaders practice supply-side discipline: capacity (plants, routes) is added rationally, returns on capital are high and rising (CTAS ROIC 16%→26%), and high returns are not attracting destabilizing new capital because the density barrier deters entrants. This is the benign quadrant of the capital cycle — incumbents earning above-cost returns protected by structural barriers, with consolidation further improving the structure. The risk to this read is precisely the thing that makes the cycle benign turning: if the leaders over-pay for consolidation (a UniFirst integration misstep) or if a softening labor market shrinks the wearer base faster than penetration gains offset.

Verdict: structurally good — among the best industry structures in industrials. Rational oligopoly, high and rising returns on capital, disciplined pricing, large underpenetrated TAM, and a density barrier that genuinely deters entry. The only structural caveat is sensitivity to aggregate employment (wearer levels), which is cyclical, not secular.


4. Competitive Position

Name the moat: economies of scale (route density) + customer captivity. In Greenwald’s taxonomy this is the strongest combination — a cost advantage from scale that is local and therefore defensible, reinforced by demand-side captivity. Cintas does not have a global brand moat or a patent; it has something more durable in this business: the densest route network in North America, and customers who don’t leave.

The density mechanism (cost advantage). Uniform rental economics are dominated by the cost of physically getting a truck to a customer and back. The more customers Cintas serves per square mile, the lower its cost per stop, the more it can invest in service/technology, and the better its margins — a flywheel a sub-scale competitor cannot enter mid-stream. Cintas’s SmartTruck routing technology and SAP/ERP backbone optimize this density continuously and, crucially, let the company absorb acquired routes (G&K, Paris Uniform, UniFirst) with minimal disruption — “incremental moves to gain efficiency over time rather than wholesale route consolidation,” per the COO. Every tuck-in increases density on existing routes, which is why acquisitions in this industry are accretive to the buyer’s unit economics, not just its revenue. This is the financial fingerprint of the moat: gross margin rising to record 50–58% across all three route businesses, and incremental operating margins of ~28–39%.

The captivity mechanism (switching costs). Retention runs ~95% — a record level management calls out every quarter. Switching costs are real if individually modest: a customer must re-source garments, re-badge employees, re-tool logistics, accept a service gap, and re-paper contracts that carry escalators and (often) loss/replacement charges. For an account spending ~$10K/year, the friction-to-savings ratio rarely justifies switching, especially since the incumbent’s density lets it price competitively. The captivity is structural, not contractual coercion — customers stay because the value proposition holds.

Low customer concentration = pricing power. With 1M+ customers and no meaningful concentration (national accounts decentralize purchasing), no single customer can extract price. This is the demand-side complement to the density moat: Cintas faces a fragmented, captive, price-taking customer base and a disciplined oligopoly of suppliers. That is why 2–3% annual pricing sticks every single year, recession or not.

Head-to-head vs. competitors. Against UniFirst (soon to be absorbed): Cintas runs structurally higher margins (UniFirst’s GM and ROIC trail materially) and far lower capex-intensity — management noted UniFirst had been spending up to “catch up on technology,” whereas Cintas is ahead on ERP/routing. Against Vestis (post-Aramark spin): Vestis has stumbled operationally and traded poorly since separation, ceding share. Against DIY/e-commerce/retail (the real two-thirds competitor): Cintas wins on the total-cost-of-ownership and consistency argument, not price. The competitive evidence — Cintas’s share gains, record retention, rising margins while peers stagnate — corroborates that the moat is widening, not eroding.

Pressure-test (the skeptic’s case). Is “density” just a story? No — it ties directly to a financial outcome that would deteriorate without it: if density were not a real cost advantage, a well-capitalized entrant (or Amazon Business) could undercut Cintas on price and take the fragmented base. It hasn’t happened in decades because the unit economics don’t work without density. Is ~95% retention durable or a function of a benign economy? Largely structural, but it would be tested in a deep employment recession when customers shrink headcount (fewer wearers) and shop harder — the genuine vulnerability. Could technology (disposable garments, gig laundry, in-house automation) disintermediate the route? Possible long-tail risk, but no evidence of it at scale; the trend is toward outsourcing, not away.

Verdict: a durable, widening competitive advantage — economies of scale (route density) plus customer captivity — that surfaces unambiguously in the financials (record margins, ~95% retention, ~26% ROIC, consistent pricing). This is a real moat, not a narrative.


5. Growth History and Forward Opportunities

History (FY19→FY25): high-quality, mostly organic, margin-accretive growth.

Metric FY19 FY20 FY21 FY22 FY23 FY24 FY25
Revenue ($B) 6.89 7.09 7.12 7.85 8.82 9.60 10.34
Revenue growth +2.8% +0.4% +10.4% +12.3% +8.9% +7.7%
Operating margin 16.7% 16.4% 19.5% 20.2% 20.4% 21.6% 22.8%
Diluted EPS ($) 2.02 2.05 2.58 2.93 3.26 3.80 4.42
ROIC 16.2% 16.4% 19.4% 20.7% 22.4% 24.4% 26.4%

The FY20–21 flat spot was COVID (employment collapse → fewer wearers), which is the clearest demonstration of the model’s one true cyclicality: revenue tracks aggregate employment/wearer levels. The snap-back and subsequent acceleration (FY22–25) combined wearer recovery, penetration gains, pricing, cross-sell, and tuck-in M&A. Critically, growth has been overwhelmingly organic — acquisitions added only ~$10–233M of cash spend per year (small relative to ~$10B revenue) until UniFirst. The margin line is the standout: ~640bps of operating-margin expansion in six years, driven by density leverage, SAP/automation, supply-chain efficiency, and mix toward higher-margin First Aid/Fire.

The growth formula (management’s own bridge). To the targeted mid-to-high-single-digit organic growth: start at −5% (lost business/wearer attrition), add +2% pricing, and the remaining ~+8–11% comes from new business (two-thirds from no-programmer/DIY conversion) plus cross-sell into the existing base. In Q3 FY26: total +8.9%, organic +8.2%, with retention ~95% and pricing in the normal 2–3% band — i.e., the growth is coming from volume/new accounts, the highest-quality source, not from price.

Forward opportunities (ranked by conviction):

  1. No-programmer conversion (highest conviction). Only ~1M of 16–20M businesses use a managed program. This is a decades-long runway and the core engine; it is share-from-unserved, not share-from-rival.
  2. Cross-sell across the route. Selling First Aid, Fire, restroom, and mat programs into existing uniform accounts — same truck, incremental high-margin revenue. First Aid (+14.6%) and Fire (+10%) organic growth show this working.
  3. Vertical penetration. Resilient verticals (healthcare, hospitality, education, government) plus under-penetrated trades/specialty (the new Ford/Carhartt three-way apparel partnership and “Apparel+” program explicitly target trades — a large, lightly-penetrated employment pool).
  4. UniFirst integration (largest but lowest-quality/risk-laden). ~$2.4B of acquired revenue, density gains, and SAP/routing synergies — but it is M&A-driven, not organic, and carries integration and antitrust risk.
  5. Continued tuck-in M&A in Fire and rental, where Cintas’s balance sheet and density make it the natural consolidator.

The forward risk: employment. Management was candid in Q3 FY26 — wearer levels are “not as robust as what we would like,” customers are “hanging on to their people” but not adding aggressively. Organic growth has decelerated from low-double-digits (FY23) to ~8% (FY26 guide). If hiring weakens further, the −5% attrition base worsens and penetration/cross-sell must work harder to hold mid-single-digit growth.

Verdict: high-quality growth — predominantly organic, volume-led, margin-accretive, with a genuinely long penetration runway — now decelerating modestly with the labor cycle. The quality of the growth (source, durability, margin contribution) is excellent; the rate is cyclically softening, which matters at a 35x multiple.


6. Financial Quality

Cintas’s financial statements are the cleanest expression of the moat — this is a business whose economics demonstrably improve with scale.

Margins and operating leverage. Gross margin rose from 45.6% (FY20) to 50.0% (FY25) and 51% in Q3 FY26; operating margin from 16.4% to 22.8%; net margin to 17.5%. Incremental operating margins of ~28–39% mean each new revenue dollar drops a high share to profit — the signature of a density/scale business with rising route utilization. EBITDA margin reached 27.6%. This is fifteen-plus years of uninterrupted margin expansion, not a one-time step.

Returns on capital. ROIC of ~26.4% (FY25), up from ~16% in FY20, against a cost of capital almost certainly in the 7–9% range — an enormous and widening spread, and the single most important number in this memo. ROE looks more pedestrian (~13%) but is understated by the moat’s success: years of buybacks have driven treasury stock to ~$9.8B and tangible book to near-zero (tangible BVPS ~$2.41), so the equity base is artificially small/loaded with goodwill from acquisitions. ROIC is the truer read, and it is exceptional.

Cash generation and conversion. Operating cash flow was $2.17B in FY25 (cash-flow-to-net-income ~1.20x — earnings convert to cash, a quality tell). After capex of ~$407M (capex intensity only ~4% of revenue — asset-light relative to its in-service-inventory base because garments are expensed/amortized through COGS), free cash flow was ~$1.76B. FCF has compounded from ~$1.1B (FY20) to ~$1.8B — and the UniFirst call noted UniFirst also generates strong cash flow, so the combined entity remains highly cash-generative.

Balance sheet. Conservative and a strategic asset. Net debt ~$2.16B at FY25 (~0.76x EBITDA); ~$2.74B at Q3 FY26. Even pro forma for UniFirst’s $2.85B bridge, management guides to only ~1.5x net-debt/EBITDA at close — investment-grade, well within capacity. Current ratio ~2.1x; ample liquidity. The one balance-sheet quirk is the large in-service inventory ($1.58B, classified within inventories) and a long cash-conversion cycle (~126 days) — both structural features of owning the garments customers wear, not signs of stress. Goodwill + intangibles (~$3.7B) reflect past acquisitions (notably G&K); watch this grow materially with UniFirst.

Quality of earnings — clean, with two flags to track. (1) SBC is modest at ~$128M (~1.2% of revenue) — not a dilution problem, and the share count is falling. (2) A FY25 one-time asset-sale gain (~60bps of margin) flattered the year-ago comp; management has been transparent about it and reports adjusted growth excluding it (e.g., Q3 FY26 op income +11% adj vs. +8.2% reported). Going forward, UniFirst transaction costs (~$0.03–0.04 EPS in FY26, broken out as a separate line from Q4) and eventual integration/amortization charges will create a GAAP-vs-adjusted gap — fair add-backs, but worth normalizing. No aggressive accounting, no revenue-recognition red flags, no off-balance-sheet alarm.

Verdict: economics emphatically improve with scale — rising margins, ~26% ROIC, strong cash conversion, conservative leverage, clean accounting. This is top-decile financial quality for the industrials sector. The only quality nuance is that ROE flatters/under-reads on the buyback-shrunk equity base; ROIC is the metric that captures the moat.


7. Capital Allocation

Management’s capital-allocation framework is explicit and consistently executed, in priority order: (1) reinvest in the business (capex, technology, route capacity); (2) strategic M&A; (3) return capital via dividends and buybacks. The track record is strong, with one large new test underway.

Reinvestment. Capex runs a disciplined ~4% of revenue, funding plants, routes, and the SAP/SmartTruck technology stack that compounds the density advantage. Management frames ongoing investment (“we are constantly investing”) as the reason margins keep expanding — and the financials corroborate it. This is high-return reinvestment (it shows up as rising ROIC), the best use of a moat’s cash.

M&A — historically excellent, now a step-change. The defining prior deal was G&K Services ($2.2B, 2017), widely regarded as a model integration that added density and was accretive. Tuck-ins (Zee Medical, Paris Uniform Services 2024, numerous Fire deals) have been small, frequent, and density-accretive. The new test is UniFirst — by far the largest deal in company history, agreed March 2026 after a multi-year pursuit (a rejected $275 all-cash bid in Jan-2025, then a negotiated $155 cash + 0.772-share structure). The strategic logic is sound (density, capacity, technology synergies, removing the #3 competitor), and Cintas’s integration muscle is proven — but the price is full, the dilution real (~14M shares), and the antitrust path uncertain. Capital-allocation judgment on this deal cannot be scored until close and integration; the framework that produced it has earned the benefit of the doubt, but the stakes are higher than any prior deal.

Shareholder returns. Cintas is a Dividend Aristocrat-quality compounder: the dividend has been raised every year for 40+ years, most recently +15.4% to $0.45/quarter, with a conservative ~34% payout ratio (ample room to keep growing it faster than EPS). Buybacks are large and steady — $934.8M in FY25, $1.53B in FY22, reducing diluted shares from ~438M (FY19) to ~410M (FY25), a ~6% reduction that adds ~1%/year to per-share growth. Importantly, buybacks are paused during the UniFirst process (signing-to-vote restrictions + quiet period) and capital is being prioritized to fund the deal — a rational sequencing, with management signaling a return to “opportunistic” buybacks once restrictions lift. Combined FY26 YTD capital returned: ~$1.45B.

Incentive alignment. The Schneider/Rozakis/Garula team has run the business with a consistent long-term, returns-focused philosophy; the proxy ties compensation to growth and returns metrics (to be validated against the latest DEF 14A in the diligence appendix). The behavioral evidence — disciplined pricing, density-accretive M&A, a falling share count, and a 40-year dividend-growth streak — indicates alignment with per-share value creation rather than empire-building. The UniFirst deal is the one data point that could read as scale-for-scale’s-sake; the structure (using stock for ~45% of consideration at a high multiple, keeping leverage at 1.5x) suggests disciplined financing rather than a debt-fueled stretch.

Verdict: management has allocated capital intelligently — high-return reinvestment, a strong M&A integration record, a 40-year dividend-growth streak, and consistent buybacks — with the UniFirst deal as a large, not-yet-scored bet whose financing discipline is reassuring but whose ultimate per-share value depends on close and integration.


8. Changes and Headwinds — Last Two Years

1) The UniFirst acquisition (the dominant change). After pursuing UniFirst since 2022 and a publicly rejected $275/share all-cash bid (Jan-2025), Cintas signed a definitive merger agreement on March 10, 2026: each UniFirst share converts to $155 cash + 0.7720 CTAS shares (~$287/share at CTAS ~$171; ~$5.3B equity value). Financing includes a $2.85B senior unsecured 364-day bridge; pro forma leverage ~1.5x at close. Break fees: UniFirst→Cintas $213.3M; Cintas→UniFirst (reverse/regulatory) $350M — the asymmetric reverse fee signals both sides priced in real antitrust risk. UniFirst shareholders approved (June 11, 2026). The same week, the FTC issued a Second Request (June 11, 2026), extending the HSR waiting period; CTAS shares fell ~5% on the news. Management guides to a 2H-calendar-2026 close but has gone silent on process. This is the single biggest swing factor in the next 12 months — a clean close adds density and accretion; a blocked deal or heavy divestiture mandate would cost $350M and waste two years of strategic effort (though it would also de-risk the balance sheet and free up buyback capacity).

2) Organic deceleration with the labor cycle. Growth has cooled from low-double-digits (FY23) to ~8% (FY26 guide). Wearer levels are soft (“not as robust as we’d like”); customers retain but don’t aggressively add headcount. This is the model’s cyclicality showing through, and it is the proximate fundamental reason (alongside multiple de-rating) the stock has lagged.

3) Record margins — but a few FY27 headwinds flagged. Gross margins hit all-time highs across all three route segments. Management flagged a ~100bps Fire-segment margin headwind in FY27 from the SAP/ERP rollout into Fire (timing-dependent), and ongoing tariff/fuel volatility (energy ~1.7% of revenue; a sustained +30% fuel move ≈ 30bps cost) — manageable, not thesis-changing.

4) Multiple de-rating. The stock’s P/E compressed from ~50x (FY25 peak) to ~35x and EV/EBITDA from ~33x to ~23.6x — a ~30% de-rating even as EPS rose ~25%. This is a valuation change, not a business deterioration, but it is the headwind that dominated total return.

5) Leadership/governance. Stable C-suite (Schneider CEO since 2021, long-tenured). 4-for-1 stock split (Sept 2024) broadened retail accessibility. No material litigation or accounting changes beyond the disclosed one-time gain and forthcoming UniFirst transaction-cost line.

Verdict: net mixed, tilting constructive on quality but with elevated near-term risk. The business is stronger than two years ago (record margins, higher ROIC, raised guidance), but the thesis now carries two new, material uncertainties — UniFirst regulatory/integration risk and labor-cycle organic deceleration — at a still-premium valuation. These weaken the near-term risk/reward without impairing the long-term franchise.


9. Risk Analysis (Risk Matrix)

Risk Likelihood Impact Evidence basis / notes
Valuation de-rating (multiple compression) Med High ~35x fwd P/E, ~23.6x EV/EBITDA, ~2.7% FCF yield; already de-rated from ~50x but still premium; AZI composite 69th pctile own-history
UniFirst antitrust block / heavy divestitures Med Med FTC Second Request issued Jun-2026; $350M reverse break fee priced the risk; #1+#3 combination invites scrutiny
UniFirst integration missteps Low-Med Med Proven integrator (G&K), but largest deal ever; ~14M-share dilution; cultural/route-density execution over 2–3 yrs
Labor-cycle / wearer-level decline Med Med-High Revenue tracks employment; mgmt flags soft wearer adds; a recession shrinks the base and pressures the −5% attrition bridge
Organic growth deceleration below mid-single Med High Already cooled to ~8%; at a 35x multiple, a slide to ~4–5% would compress both EPS growth and the multiple
Input cost shocks (fuel, cotton, tariffs) Med Low Energy ~1.7% of revenue (~60% vehicle fuel); no fuel surcharge but offsets via efficiency; tariffs immaterial per mgmt
Technological disintermediation (DIY/automation/disposables) Low Med-High No evidence at scale; trend is toward outsourcing; long-tail risk to the route model
Customer concentration Very Low Low 1M+ customers, avg ~$10K/yr, national accounts decentralized — effectively no concentration
Balance-sheet / financing Low Low ~0.76x net leverage; ~1.5x pro forma; investment-grade; strong FCF
Key-person Low Low Deep, long-tenured bench; founder-family legacy culture institutionalized
Catastrophic / total loss Very Low High Diversified, cash-generative, low leverage, no single point of failure — total-loss risk is negligible

Aggregate read: the dominant risks are valuation and organic-growth deceleration (the two are linked — a growth slowdown would trigger a de-rating), followed by the binary UniFirst regulatory outcome. Operational, balance-sheet, concentration, and key-person risks are low. There is no plausible path to catastrophic capital impairment; the realistic downside is multiple compression on decelerating growth — a 20–35% drawdown of the kind already partly experienced — not a permanent loss.


10. Valuation Discussion (Embedded Expectations)

No price target, no recommendation — this section frames what the current price embeds.

Where the multiple sits. At ~$171 (mkt cap ~$68.9B; net debt ~$2.74B; EV ~$71.6B):

Multiple Current (TTM/fwd) FY25 peak FY20 Own-history percentile (AZI)
P/E (TTM) ~36x ~50x ~29x 56th
P/E (FY26 fwd, adj) ~35x
EV/EBITDA (TTM) ~23.6x ~33x ~18x — (P/S 76th, P/B 76th)
EV/Sales ~6.5x ~9x ~4x 75th
P/FCF ~37x ~43x ~21x
FCF yield ~2.7% ~2.3% ~4.9%
Dividend yield ~1.05%
AZI composite own-history percentile 69th ~95th+ low

The critical own-history fact: CTAS is at the 69th percentile of its own ~10-year valuation range — richer than average but well off the 95th-percentile extremes of 2024–25 and of the recent comparable-quality cohort. The P/E percentile is only the 56th. The de-rating is genuine and meaningful, but the stock is not “cheap” on any absolute metric — a ~2.7% FCF yield and ~35x forward earnings are premium prices that require sustained double-digit compounding to deliver an attractive forward return without further multiple help.

Embedded-expectations (reverse) analysis. Holding the current ~23.6x EV/EBITDA constant, total return ≈ EBITDA/EPS growth + dividend (~1%) − dilution. The market is underwriting roughly: ~8% organic revenue growth, continued ~50–100bps/year margin expansion, ~10–11% EPS growth (FY26 guide), and the UniFirst deal closing with accretion — i.e., a continuation of the exact trajectory of the last decade. What the market is pricing correctly: the durability of the moat, the high ROIC, the pricing power, the conservative balance sheet. What it may be pricing too optimistically: that organic growth holds at ~8% through a softening labor cycle, that the UniFirst deal closes cleanly and accretively, and that a ~35x multiple is sustainable if growth slips toward mid-single-digits. What it may be pricing too pessimistically (the bull rejoinder): the stock has already de-rated ~30%, the penetration runway is genuinely long, and a clean UniFirst close would add density economics the market is currently discounting for regulatory risk.

Scenario sketch (illustrative, not targets).

  • Bear: organic decelerates to ~4–5%, UniFirst blocked or value-dilutive, multiple compresses toward ~18x EV/EBITDA / ~28x P/E — a further ~20–30% de-rating despite flat/modestly-growing earnings. (Tangible downside is multiple, not earnings collapse.)
  • Base: ~7–8% organic, ~10% EPS growth, UniFirst closes and is modestly accretive by FY28, multiple drifts to ~21–23x EV/EBITDA — high-single-digit annualized total return, mostly from earnings.
  • Bull: organic re-accelerates toward double-digits, UniFirst closes accretively and density compounds, multiple holds ~24x+ — low-to-mid-teens total return.

SOTP / deal math. UniFirst’s ~$2.4B revenue at Cintas-class margins is worth more inside Cintas than standalone (the synergy/density case), supporting the strategic logic; but at ~$5.3B for ~$2.4B revenue (~2.2x sales) plus ~14M shares of dilution, the deal needs full synergy realization to be clearly per-share accretive beyond FY27 — it is a good deal, not a cheap one.

Embedded-expectations verdict: the price embeds a continuation of an exceptional track record with little margin for error on growth, multiple, or the UniFirst close. The de-rating has improved the entry meaningfully versus 2024–25, but ~35x forward earnings still requires the franchise to keep compounding at the top of its historical range.


11. Variant Perception

Consensus belief. Cintas is a best-in-class compounder (“the SYK/quality-industrial of business services”) deserving a premium multiple; the recent weakness is a digestible pause driven by labor softness and deal overhang; sell-side remains constructive (e.g., Truist maintains Buy, albeit trimming its PT to ~$225). The factor tape confirms the positioning: CTAS’s nearest neighbors are low-vol/quality/dividend ETFs (SPLV, USMV, NOBL) and Stryker — it is owned as a defensive quality-compounder, with momentum loadings now zeroed (the 12-month decline has wrung out the momentum crowd) and no Value loading (it isn’t cheap). Beta ~0.67; this is a low-vol, quality-factor name that has lost its momentum bid.

Strongest bull case. A genuinely wide-moat, ~26%-ROIC compounder with a decades-long penetration runway and a proven consolidation playbook is on sale for the first time in years (69th percentile own-history vs. 95th+). Buy great businesses when their multiple resets, not when it peaks; the UniFirst deal — if it clears — adds density economics the market is under-crediting amid regulatory fear. Time arbitrages the overhang.

Strongest bear case. A 35x forward multiple and ~2.7% FCF yield leave no margin of safety for a business whose growth is decelerating and whose single biggest lever (wearer/employment levels) is softening. The UniFirst deal could be blocked (FTC Second Request; #1+#3) costing $350M and credibility, or close and disappoint on integration/dilution. The de-rating from 50x to 35x may be the first half of a reversion toward the franchise’s pre-2023 ~25–30x norm — meaning further downside even if the business executes.

The 3–5 assumptions that matter most:

  1. Organic growth holds ≥ mid-single-digits through the labor cycle (bull needs ~7–8%; bear sees ~4–5%).
  2. The multiple doesn’t revert below ~20x EV/EBITDA — i.e., the quality premium is structural, not a 2023–24 liquidity artifact.
  3. UniFirst closes, on roughly agreed terms, and integrates accretively (vs. blocked / heavily divested / value-dilutive).
  4. Margin expansion continues (offsetting the FY27 Fire-ERP headwind) — the moat keeps widening.
  5. Capital discipline holds — buybacks resume post-deal, no debt-fueled empire-building.

What would falsify each side. Falsify the bull: two+ quarters of organic growth printing ≤5% with retention slipping below ~93%, or an FTC block. Falsify the bear: organic re-accelerating toward double-digits with margins still expanding, and a clean accretive UniFirst close — which would re-rate the stock and validate the premium.

Variant takeaway: consensus and the tape agree this is a quality name that de-rated; the genuine variant question is narrower and binary-ish — is 35x forward the floor of a permanent quality premium, or the midpoint of a reversion to ~28x? The factor read (momentum gone, no value support yet) says the de-rating may not be finished, which is why “accumulate on further weakness” beats “buy here” for a price-sensitive owner.


12. Fact vs. Interpretation

# Statement Fact / Interpretation Basis
1 FY25 revenue $10.34B; diluted EPS $4.42; operating margin 22.8%; ROIC ~26.4% Fact ROIC.ai / 10-K FY25
2 Operating margin expanded ~640bps FY19→FY25; gross margin crossed 50% Fact ROIC.ai income statement
3 The moat is economies-of-scale (route density) + customer captivity Interpretation Greenwald framework applied to retention/margin/ROIC evidence
4 ~95% retention and 2–3% annual pricing reflect durable pricing power Fact (metrics) / Interpretation (durability) Q3 FY26 call
5 UniFirst deal: $155 cash + 0.772 CTAS shares; ~$5.3B; ~1.5x pro forma leverage; $350M reverse fee Fact 8-K 2026-03-11 (merger agreement)
6 FTC Second Request (Jun-11-2026) creates real, but not majority-likely, block risk Fact (request) / Interpretation (probability) 8-K 2026-06-12
7 Stock down ~24% from June-2025 peak; at 69th-pctile own-history valuation Fact AZI price CSV + valuation_index
8 The decline is multiple de-rating + deal overhang + organic deceleration, not business impairment Interpretation Price/earnings reconciliation; transcript
9 ~35x forward P/E embeds continued double-digit EPS growth with little error margin Interpretation Reverse-valuation analysis
10 Factor profile: LowVol/Quality/Dividend; momentum zeroed; no Value loading Fact FactorsToday loadings/related-stocks
11 Industry is a rational, consolidating oligopoly in the benign quadrant of the capital cycle Interpretation Marathon framework; pricing/retention/share evidence
12 FY26 guide: revenue $11.21–11.24B; adj diluted EPS $4.86–4.90 Fact Q3 FY26 call / 8-K 2026-03-25

13. Open Questions

  1. Will the FTC clear UniFirst — outright, with divestitures, or block it? What divestiture remedy would still leave the deal accretive? (Gating, binary, 2H-CY2026.)
  2. How low does organic growth go if employment continues to soften? Is mid-single-digit the floor, or does it test ~3–4% in a recession?
  3. What is the realistic UniFirst synergy number and accretion timeline — and per-share accretion after ~14M shares of dilution? (Management has not quantified synergies publicly.)
  4. Does the quality multiple have a structural floor, or is the 50x→35x move the start of a reversion toward the pre-2023 ~25–30x range?
  5. Post-deal capital allocation: how aggressively do buybacks resume once restrictions lift, and at what leverage ceiling?
  6. Incentive specifics: do the latest proxy’s metrics tie pay to ROIC/returns (not just growth)? (To validate against DEF 14A.)
  7. FY27 margin bridge: can continued density/SAP gains fully offset the ~100bps Fire-ERP headwind?

14. What Must Be True

Bull case — what must be true:

  • Organic growth holds ≥ ~7% through the labor cycle (penetration/cross-sell offsetting soft wearer adds).
  • Margins keep expanding (~50–100bps/yr), absorbing the FY27 Fire-ERP headwind.
  • UniFirst closes on ~agreed terms and is per-share accretive by ~FY28; density economics compound.
  • The quality premium proves structural — multiple holds ≥ ~21–23x EV/EBITDA.
  • Falsification test: two consecutive quarters of organic growth ≤5% with retention slipping below ~93%, OR an FTC block of UniFirst. Either would break the “durable compounder, fairly priced” thesis.

Bear case — what must be true:

  • Labor softness deepens; wearer levels and organic growth slide toward mid-single-digits or below.
  • The 35x forward multiple reverts toward the franchise’s pre-2023 ~25–30x norm regardless of execution.
  • UniFirst is blocked/heavily-divested or closes and disappoints (integration, dilution), consuming capital and attention.
  • Falsification test: organic growth re-accelerating toward double-digits with margins still expanding AND a clean, accretive UniFirst close. Either of the last two — re-acceleration or a clean close — would invalidate the “first half of a reversion” bear case and likely re-rate the stock.

Synthesis: the franchise quality is not seriously in dispute on either side; the debate is entirely about price and the two swing variables — the trajectory of organic growth and the UniFirst outcome. That is why the honest stance is a quality-aware hold with a bias to accumulate on further weakness, not a high-conviction buy at ~35x forward or a short of a 26%-ROIC compounder.


15. Source Appendix

See the separate Appendix B — Source Appendix (stitched into the combined report) for the full source list. Primary sources: Cintas FY25 Form 10-K (filed 2025-07-28), Q3 FY26 Form 10-Q (2026-04-07), merger 8-K (2026-03-11), S-4 (2026-04-27), FTC-Second-Request 8-K (2026-06-12), DEF 14A; Q3 FY26 earnings call transcript (2026-03-25). Quantitative data: ROIC.ai (statements, ratios, EV, multiples), AZI (valuation-index own-history percentiles, price history, news), FactorsToday (factor loadings, leaderboard, related stocks). All accessed 2026-06-20.


APPENDIX A — Standard Diligence Questionnaire

Cintas Corporation (NASDAQ: CTAS) — Standard Diligence Questionnaire

Supplemental diligence appendix. Companion to the research memo; not counted toward the memo length standard. Fact / Interpretation / Assumption labels applied where it matters. Report date: 2026-06-20.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debates: (1) Can a 26%-ROIC compounder justify a 35x forward multiple as growth decelerates? (the perennial “great business / what price” question); (2) Will the UniFirst deal clear the FTC, and is it accretive after dilution?; (3) How cyclical is the model really — i.e., how far do wearer levels fall in a recession?; (4) Is the moat eroding from DIY/e-commerce or technology, or widening (the evidence says widening); (5) Is margin expansion near a ceiling after 15 years and a 51% gross margin? On the Q3 FY26 call, analysts (William Blair, Goldman, Baird, Barclays, UBS, Truist, JPM, RBC, BNP, Deutsche) focused heavily on fuel/energy sensitivity, SG&A normalization vs. the prior-year one-time gain, UniFirst capex/integration, wearer-level/employment trends, and Q4 organic comps — i.e., near-term modeling and the deal, not the moat.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: near a structural high in margin (record 51% GM, 22.8% op margin) but not an unsustainable cyclical peak — these are the product of a 15-year secular density/efficiency trend, not a one-off boom. Revenue growth, however, is decelerating from a cyclical-ish high (low-double-digits FY23 → ~8% FY26) as employment cools, so the growth rate is moderating from above-trend.

Driven by external environment or internal actions? Both, but predominantly internal — margin expansion comes from density, SAP/SmartTruck efficiency, supply-chain execution, and mix. The external lever is employment/wearer levels, which sets the volume base.

How stable are revenues? Fact: among the most stable in industrials — recurring, contractual, ~95% retention, 1M+ diversified customers. The only material wobble in 20 years was FY20–21 (COVID employment collapse), and even then revenue was roughly flat, not down sharply.

Outlook for products/services; how big is the market? Large and underpenetrated — ~1M of 16–20M U.S./Canada businesses use a managed program; ~180M workers. Growing (penetration + cross-sell + pricing), primarily domestic (U.S./Canada/Latin America), with a multi-decade conversion runway.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Less — consolidation (G&K, Vestis spin/stumble, pending UniFirst) is concentrating the organized market into a more rational oligopoly; the principal “competitor” remains DIY/no-programmer, not a price war among incumbents.

How profitable is the business? Exceptionally: ROIC ~26%, operating margin 22.8%, gross margin 50%+, FCF ~$1.8B. Fact.

How profitable is the industry; barriers to entry? High and rising returns for the leaders; the key barrier is local route density (a structural cost advantage that deters entry), plus capital for plants/fleet and the technology backbone. Pricing discipline (2–3%/yr industry-wide) reflects rational competition.

Can the business be easily understood? Yes — “rent and launder uniforms/mats, restock supplies, inspect fire equipment, on a weekly route.” Simple, durable, predictable.

Can it be undermined by foreign low-cost labor? No — it is an inherently local, physical, route-based service (trucks visiting U.S./Canada sites). Garment manufacturing has some offshore input (tariff-exposed but immaterial per management); the service itself cannot be offshored.

Do brands matter / nature of competition / switching costs? The Cintas brand carries trust/reliability weight, but the moat is density + switching costs, not brand per se. Switching costs are real-but-modest (re-sourcing, re-badging, logistics, contracts) and underpin ~95% retention. Competition is for the unserved account more than for a rival’s account.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Interpretation: the customer relationships/route density (the actual moat) and the brand are largely unrecognized except as acquired goodwill/intangibles (~$3.7B). The owned garment fleet is on the balance sheet as in-service inventory (~$1.58B).

Off-balance-sheet liabilities? Operating leases (capitalized under current standards); no alarming off-balance-sheet exposure identified. The new $2.85B UniFirst bridge is on-balance-sheet at close.

How conservative is the accounting? Conservative and clean — earnings convert to cash (CFO/NI ~1.2x), modest SBC (~1.2% of revenue), transparent disclosure of the FY25 one-time gain and forthcoming UniFirst transaction-cost line. No revenue-recognition or aggressive-capitalization flags.

How CapEx-hungry? Moderately light — capex ~4% of revenue. The capital intensity hides in in-service inventory (garments), funded through working capital/COGS amortization rather than headline capex. UniFirst’s higher capex intensity (“catching up on technology”) may nudge combined capex up modestly post-close.

Capital Allocation & Management

FCF generation and use; philosophy? ~$1.8B FCF/yr. Stated priority: (1) reinvest (capex/tech), (2) strategic M&A, (3) return capital (dividends + buybacks). Consistently executed.

Significant recent acquisitions? UniFirst ($5.3B, agreed March 2026) — transformational, pending FTC. Prior: G&K Services ($2.2B, 2017, model integration), Paris Uniform (2024), Zee Medical, numerous Fire tuck-ins.

Buying back shares? Yes — $934.8M (FY25), reducing diluted shares ~438M→410M over six years; paused during the UniFirst process, expected to resume opportunistically post-restrictions.

Issuing large amounts to insiders? No — modest SBC; net share count falling. UniFirst will issue ~14M new shares as deal consideration (a one-time ~3.5% dilution), not insider issuance.

Compensation policy / motivations of management? Assumption pending DEF 14A validation: long-term, returns-oriented; behavioral evidence (disciplined pricing, accretive M&A, falling share count, 40-year dividend-growth streak) indicates alignment with per-share value creation. The UniFirst deal is the one item to watch for scale-for-scale’s-sake; the stock-heavy, 1.5x-leverage financing reads as disciplined.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — a U.S. C-corporation (Washington-incorporated), single class of common, NASDAQ-listed (ticker CTAS), standard 1099 dividend treatment.

Dividend policy? Dividend Aristocrat-class: raised every year for 40+ years; most recent +15.4% to $0.45/quarter; ~34% payout (room to keep growing > EPS); current yield ~1.05%.

How profitable is the business? (See above — ROIC ~26%, op margin 22.8%.) Top-decile.

Is net income diverging from cash from operations? No — CFO consistently exceeds net income (~1.2x), a positive quality signal; no divergence concern.

Risks & Downside

What factors would cause the stock to decline? Multiple de-rating (the primary risk at 35x fwd), organic-growth deceleration with the labor cycle, an FTC block or value-dilutive UniFirst outcome, a margin-expansion stall, or a broad quality/low-vol factor unwind.

Risk of a catastrophic loss? Very low — diversified, cash-generative, ~0.76x (1.5x pro forma) leverage, no customer concentration, no single point of failure.

Chance of a total loss? Negligible. The realistic downside is a 20–35% drawdown from multiple compression on decelerating growth — not permanent capital impairment.

Recent News & Events

Has the business environment changed recently? Yes, in two ways: (1) UniFirst merger signed March 2026, UNF holders approved June 2026, now in FTC Second Request (timeline extended) — the dominant event; (2) labor softening pressuring wearer levels and organic growth (~8%). Margins are at record highs.

Significant acquisitions? UniFirst (pending) — see above.

Change in accounting policies? None material; UniFirst transaction costs to be broken out as a separate income-statement line from Q4 FY26.

Recent changes — new markets/facilities/management? Stable management (CEO Schneider since 2021); 4-for-1 stock split (Sept 2024); new trades-focused initiatives (Ford/Carhartt three-way apparel partnership, “Apparel+”); ongoing SAP rollout into the Fire segment (~100bps FY27 margin headwind).


APPENDIX B — Source Appendix

Cintas Corporation (NASDAQ: CTAS) — Source Appendix

All sources accessed 2026-06-20 unless noted. Primary sources (filings, transcripts) prioritized over secondary. Quantitative figures cross-checked against SEC filings where the aggregator is third-party.

Primary — SEC Filings (EDGAR, CIK 0000723254)

Source Date Use
Form 10-K, FY2025 (period end 2025-05-31) filed 2025-07-28 Segment detail, FY25 financials, business description, risk factors
Form 10-Q, Q3 FY2026 (period end 2026-02-28) filed 2026-04-07 Latest balance sheet, net debt, share count, quarterly results
Form 10-Q, Q1/Q2 FY2026 2025-10-08 / 2026-01-07 Interim trend
Form 10-K, FY2021–FY2024 2021–2024 5-year revenue/margin/EPS/ROIC history
Form 8-K — UniFirst merger agreement 2026-03-11 Deal terms: $155 cash + 0.7720 CTAS shares; $2.85B bridge; $213.3M / $350M break fees
Form 8-K — Q3 FY26 results & raised guidance 2026-03-25 FY26 guide: rev $11.21–11.24B; adj EPS $4.86–4.90
Form S-4 — merger registration 2026-04-27 Stock-consideration registration, deal mechanics
Form 8-K — FTC Second Request / UNF shareholder approval 2026-06-12 HSR extended 30 days; UNF holders approved 2026-06-11
Form 425 filings (merger communications) 2026-03 to 2026-05 Deal investor materials
DEF 14A / proxy (FY2025) 2025-09 Compensation/incentive structure (to validate)
Form 4 (insider transactions) corpus 2021–2026 Insider activity (routine grants/sales; no notable open-market buy signal)

Primary — Transcript

Source Date Use
Cintas Q3 FY2026 earnings call transcript (Schneider/Rozakis/Garula) 2026-03-25 Organic growth by segment, retention/pricing, growth formula, UniFirst commentary, energy/fuel, FY27 Fire-ERP headwind, capital allocation

Public Data Sources

Source Use
Public fundamental data (company filings) Income statement, balance sheet, cash flow, profitability ratios (ROIC/ROE/margins), per-share data, enterprise value, valuation multiples, company profile (FY2019–FY2025 + TTM)
Historical valuation-range data Own-history valuation percentiles: composite 69th; P/E 56th, P/B 76th, P/S 75th
Public price history 5-year split/dividend-adjusted OHLC, EMAs, beta — used for the Five-Year Event Map
Financial news (Benzinga and others) UniFirst/FTC news items; sell-side PT change (Truist → $225)
Factor/quantitative positioning data (public) Factor loadings (LowVol/Quality/Dividend; momentum zeroed; market beta), leaderboard (risk-adjusted returns, drawdowns), related-stocks (SPLV/USMV/NOBL/SYK), stock-info (rs_12m −22%, beta 0.67)

Secondary / Trade Press

Source Date Use
Benzinga — “Cintas and UniFirst Receive FTC Requests for More Information…” 2026-06-12 FTC Second Request; HSR 30-day extension; UNF shareholder approval
Benzinga / Truist Securities note (via AZI) — “Maintains Buy on Cintas, Lowers PT to $225” 2026-06-15 Consensus positioning

Key Figures Quick-Reference (as used in the memo)

  • Price (2026-06-18): $170.85; mkt cap ~$68.9B; net debt ~$2.74B (Q3 FY26); EV ~$71.6B
  • FY25: revenue $10.34B; diluted EPS $4.42; op margin 22.8%; gross margin 50.0%; ROIC 26.4%; FCF ~$1.76B
  • TTM (Q3 FY26): revenue $11.03B; EBITDA $3.03B; EBIT $2.53B; EPS ~$4.748
  • Valuation: P/E ttm ~36x; fwd P/E ~35x; EV/EBITDA ~23.6x; EV/Sales ~6.5x; P/FCF ~37x; div yield ~1.05%
  • 5-yr price: low ~$83 (Jun-2021) → high ~$225 (Jun-2025) → ~$171 (−24% off high); 52wk $163–$224; beta 0.67
  • UniFirst deal: $155 cash + 0.7720 CTAS/sh (~$287, ~$5.3B); ~1.5x pro forma leverage; close 2H-CY2026; FTC Second Request pending